The researchers found that a biomarker in the blood called neurofilament light chain (NfL) increased after menopause. This ...
Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...
When he was 25, he learned that he had multiple sclerosis. He coped with the disease throughout a long career at several ...
Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.
Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...
A team of doctors in Mumbai treated a 24-year-old engineering student who was suffering from multiple sclerosis, a chronic disease that affects the nervous system. For the patient, Sushant Chavan, ...
Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback